Retatrutide 24MG (GLP-3RT)

Normal retail price: $220.00

Total for 20 units: $3,000.00
Based on tiered pricing: $150.00 per unit

Multi-pathway peptide studied for significant weight loss and insulin regulation.

Description

Also known as: LY3437943
CAS Number: 2381089-83-2
Molecular Formula: C187H291N51O60
Molecular Weight: ~4260 g/mol
Form: Lyophilized Powder
Quantity: 24mg
Purity: ≥ 98% (HPLC Verified)

Thank you for reading this post, don't forget to subscribe!


Product Overview:

Retatrutide is a novel investigational peptide that functions as a triple receptor agonist—targeting GLP-1, GIP, and glucagon receptors. This multifaceted mechanism is being actively studied for its ability to enhance metabolic function, reduce body weight, and improve insulin sensitivity more effectively than single or dual agonists.

Its research relevance is rapidly growing in:

  • Obesity and weight loss models

  • Type 2 diabetes and glucose regulation studies

  • Lipid metabolism and energy expenditure research

  • Explorations into multi-hormonal metabolic therapies


Applications in Research:

  • Studies comparing GLP-1/GIP/glucagon synergy

  • Investigations into body fat reduction and energy balance

  • Research into glycemic control and insulin response

  • Preclinical trials of next-generation incretin mimetics

 

Clinical Data:

GLP-3RT: Triple–Hormone-Receptor Agonist for Obesity — A Phase 2 Trial

GLP-3RT: A Study (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3)

GLP-3RT: Triple-Hormone-Receptor Agonist Study for Obesity – A Phase 2 Trial

 


Storage & Handling:

Store lyophilized Retatrutide at -20°C in a dark, dry location.
Reconstitute with bacteriostatic water using sterile technique. Once reconstituted, refrigerate at 2–8°C and use within standard research timelines. Avoid multiple freeze-thaw cycles.


⚠️ Research Use Only – Legal Disclaimer

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Simple Peptide is a chemical supplier. Simple Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Simple Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.